Skip to Content
Contact Form Map & Directions Videos

J&J Gets $1.2 Billion Pass on Risperdal Fine

03/27/2014
Defective Drugs
BY

Two years ago, healthcare giant Johnson & Johnson was facing a $1.2 billion judgment after a jury determined J&J concealed the risks of its antipsychotic drug Risperdal while it aggressively and improperly marketed it off-label. At the time it was the largest state fine over the mismarketing of Risperdal and […]

Read More

Brenda Fulmer Featured in Trial Magazine

03/25/2014
Announcement
BY

Congratulations, Brenda! We’ve reprinted the article below. Reprinted with permission of Trial (March 2014) Copyright American Association for Justice, formerly Association of Trial Lawyers of America (ATLA®) Gender equity in the law March 2014, Volume 50, No. 3 Sidebar: Brenda Fulmer: Working hard and staying true  Courtney L. Davenport When […]

Read More

Living Off the Label

03/24/2014
Articles
BY

Doctors and physicians are given a great deal of discretion when it comes to prescribing drugs for uses other than those indicated by the FDA. This is known as “off-label” use. The FDA, realizing the danger of off-label promotion in its 2009 guidance, has set forth rules to restrict the […]

Read More

Drug Supplement Endangers Kids

03/19/2014
Articles
BY

It is a supplement used to treat children with a genetic disorder but instead has hospitalized at least one child. The Food and Drug Administration (FDA) reports lots of L-citrulline, sold by Medisca, had none of the active drug. The Plattsburgh, N.Y.-based compounding company was forced to recall eight lots […]

Read More

Hear What Our Clients Have To Say

"Cannot say enough about Mr. Ward and his team. Joanna and Mr. Ward helped me through a very difficult time while being extremely professional and prompt. I would highly recommend."
Posted By: Samantha Saundry